Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BLOXIVERZ | Exela Pharma Sciences | N-204078 RX | 2013-05-31 | 3 products, RLD, RS |
NEOSTIGMINE METHYLSULFATE | Fresenius Kabi | N-203629 RX | 2015-01-08 | 3 products, RLD, RS |
Code | Description |
---|---|
J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuromuscular blockade | D019148 | — | — | 2 | 4 | 6 | 25 | 10 | 46 |
Delayed emergence from anesthesia | D055191 | — | — | — | 2 | — | 9 | 8 | 19 |
Postoperative pain | D010149 | — | G89.18 | 1 | 2 | 1 | 2 | 5 | 10 |
General anesthesia | D000768 | — | — | 1 | 3 | 5 | 1 | 1 | 10 |
Anesthesia | D000758 | — | — | — | — | 2 | 3 | 2 | 7 |
Post-dural puncture headache | D051299 | — | — | — | 1 | 1 | 3 | — | 5 |
Spinal cord injuries | D013119 | EFO_1001919 | — | 4 | — | — | 1 | — | 5 |
Postoperative complications | D011183 | — | — | — | 1 | — | 2 | 1 | 4 |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | 1 | 1 | 2 | 4 |
Muscle relaxation | D009126 | — | — | — | — | — | 3 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Morbid obesity | D009767 | EFO_0001074 | — | — | 1 | 1 | — | 2 | 3 |
Hypospadias | D007021 | EFO_0004209 | Q54 | — | 1 | 1 | — | — | 1 |
Burns | D002056 | — | T30.0 | — | — | 1 | — | — | 1 |
Muscle fatigue | D018763 | — | — | — | — | 1 | — | — | 1 |
Elective surgical procedures | D017558 | — | — | — | — | 1 | — | — | 1 |
Replacement arthroplasty knee | D019645 | — | — | — | — | 1 | — | — | 1 |
Replacement arthroplasty hip | D019644 | — | — | — | — | 1 | — | — | 1 |
Blood coagulation | D001777 | GO_0007596 | — | — | — | 1 | — | — | 1 |
Knee injuries | D007718 | — | — | — | 1 | 1 | — | — | 1 |
Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Septic shock | D012772 | — | A48.3 | — | 1 | — | — | — | 1 |
Pancreatitis | D010195 | HP_0001733 | K85 | — | 1 | — | — | — | 1 |
Intra-abdominal hypertension | D059325 | — | — | — | 1 | — | — | — | 1 |
Systemic inflammatory response syndrome | D018746 | EFO_1001478 | R65.10 | 1 | 1 | — | — | — | 1 |
Obstructive jaundice | D041781 | EFO_1001068 | — | 1 | 1 | — | — | — | 1 |
Urinary retention | D016055 | HP_0000016 | R33 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neurogenic bowel | D055496 | EFO_1001061 | K59.2 | 4 | — | — | — | — | 4 |
Constipation | D003248 | HP_0002019 | K59.0 | 2 | — | — | — | 1 | 3 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | — | — | — | — | 1 |
Labor pain | D048949 | — | — | 1 | — | — | — | — | 1 |
Fecal incontinence | D005242 | — | R15 | 1 | — | — | — | — | 1 |
Snoring | D012913 | — | R06.83 | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Critical illness | D016638 | — | — | — | — | — | — | 3 | 3 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 2 | 2 |
Gallbladder diseases | D005705 | EFO_0003832 | K82.9 | — | — | — | — | 2 | 2 |
Acute pain | D059787 | — | R52 | — | — | — | — | 2 | 2 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | — | — | — | — | 2 | 2 |
Analgesia | D000698 | — | — | — | — | — | — | 2 | 2 |
Conduction anesthesia | D000765 | — | — | — | — | — | — | 1 | 1 |
Hysterectomy | D007044 | EFO_0003881 | — | — | — | — | — | 1 | 1 |
Electroencephalography | D004569 | — | — | — | — | — | — | 1 | 1 |
Sleep | D012890 | GO_0030431 | — | — | — | — | — | 1 | 1 |
Drug common name | Neostigmine |
INN | neostigmine bromide |
Description | Neostigmine is a quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor and an antidote to curare poisoning. |
Classification | Small molecule |
Drug class | cholinesterase inhibitors (physostigmine type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1 |
PDB | — |
CAS-ID | 59-99-4 |
RxCUI | — |
ChEMBL ID | CHEMBL278020 |
ChEBI ID | 7514 |
PubChem CID | 4456 |
DrugBank | DB01400 |
UNII ID | 005SYP50G5 (ChemIDplus, GSRS) |